Treatment of multiple sclerosis with brain targeted anti oxidant compounds

Details for Australian Patent Application No. 2003247144 (hide)

Owner Yissum Research Development Company of The Hebrew University of Jerusalem Ramot At Tel Aviv University Ltd. MOR Research Applications Ltd.

Inventors Melamed, Eldad; Atlas, Daphne; Offen, Daniel

Agent Cullen & Co

Pub. Number AU-B-2003247144

PCT Number PCT/IL03/00635

PCT Pub. Number WO2004/012652

Priority 60/400,114 02.08.02 US

Filing date 31 July 2003

Wipo publication date 23 February 2004

Acceptance publication date 29 November 2007

International Classifications

A61K 31/00 (2006.01)

Event Publications

2 October 2003 Complete Application Filed

  Priority application(s): 60/400,114 02.08.02 US

1 April 2004 Application Open to Public Inspection

  Published as AU-B-2003247144

29 November 2007 Application Accepted

  Published as AU-B-2003247144

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003247145-SIM2 POLYPEPTIDES AND POLYNUCLEOTIDES AND USES OF EACH IN DIAGNOSIS AND TREATMENT OF OVARIAN, BREAST AND LUNG CANCERS

2003247143-Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels